226 results
8-K
EX-10.1
BAX
Baxter International Inc.
21 Mar 24
Entry into a Material Definitive Agreement
4:32pm
, supplemented or modified from time to time, or (c) to be a commitment or any other undertaking or expression of any willingness to engage in any further
8-K
EX-10.2
BAX
Baxter International Inc.
21 Mar 24
Entry into a Material Definitive Agreement
4:32pm
to time, or (c) to be a commitment or any other undertaking or expression of any willingness to engage in any further discussion with the Borrower
8-K
ydhhhp
4 Mar 24
Regulation FD Disclosure
8:30am
8-K
EX-99.1
511fd 3fxov0s
8 Feb 24
Baxter Reports Fourth-quarter and Full-year 2023 Results
7:18am
8-K
EX-99.1
t8brhzkt0x
27 Jul 23
Baxter Reports Second-quarter 2023 Results
7:33am
8-K
EX-99.1
jhtoyr
6 Jul 23
Regulation FD Disclosure
8:30am
8-K
EX-99.1
31cjoz
9 May 23
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to
8:42am
8-K
EX-2.1
lduubp74b0p9bewnj
9 May 23
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to
8:42am
8-K
EX-3.1
dxmguz 1a13
9 May 23
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to
8:42am
8-K
EX-99.1
q7gus61nb rz10kh7
27 Oct 22
Baxter Reports Third-quarter 2022 Results
7:18am
8-K
EX-10.4
znesw0
30 Sep 22
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-10.2
wzv301d
30 Sep 22
Entry into a Material Definitive Agreement
4:16pm